Table of Contents Table of Contents
Previous Page  478 / 812 Next Page
Information
Show Menu
Previous Page 478 / 812 Next Page
Page Background

S474

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805

sociodemographic factors, depression comorbidity and antidepres-

sive treatment.

Results

One thousand four hundred and fifty-two patients

matched DSM-V delusional disorder criteria. 49,8% of our sample

were women. Average following period was 9 years and 1 month,

with an average of 0,84 hospitalizations. The prevalence of depres-

sion in patients with delusional disorders was 31,9%. 67,5% of them

received some kind of antidepressive treatment. The antidepres-

sive drugs most frequently used were selective serotonin reuptake

inhibitors.

Conclusions

Depression is a highly prevalent condition among

patients with delusional disorder. Most of them are on antidepres-

sive treatment, the most employed of which is based on selective

serotonin reuptake inhibitors. Comorbid depression can have an

important impact on the course of delusional disorder. A correct

diagnosis and treatment should be made to help improve the prog-

nosis and life quality of these patients.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1377

EV393

Anxiety disorders and substance abuse

I. Prieto Sánchez

, M.D.L.C. Ramírez Domínguez ,

S. Fernández León , M. Reina Domínguez , N. Garrido Torres ,

A. Rodríguez Martínez , A.S. Biedma Martín , C. González Macías

Complejo Hospitalario Universitario de Huelva Juan Ramón Jimenez,

Unidad de Salud Mental, Huelva, Spain

Corresponding author.

Introduction

Patients with anxiety disorders aremore vulnerable

to develop other comorbid conditions. In particular, large epi-

demiological studies show a strong association between different

anxiety disorders and substance use disorders.

Objectives

To showthe prevalence ofmajor anxiety disorders and

the consumption of different substances. As well as the particu-

lar characteristics of this dual diagnosis and treatments that have

proven more effective.

Methods

Exhaustive review of all the material published on this

topic in the recent years.

Conclusions

Nearly 24% of patients with anxiety disorder suffer

from a comorbid substance disorder use in their lifetime (17.9%

diagnosis of alcohol abuse or dependence diagnosis and 11.9% of

abuse or dependence on other drugs). Dual patients show a number

of distinctive features, such as more frequency in males, family his-

tory of alcohol or other substances abuse and behavioral problems,

early parental loss among others.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1378

EV394

Dual diagnosis (Depression and

addictions): Special considerations

I. Prieto Sánchez

, M.D.L.C. Ramírez Domínguez ,

A. Rodríguez Martínez , N. Garrido Torres , M. Reina Domínguez ,

A.S. Biedma Martín , C. González Macías

Complejo Hospitalario Universitario de Huelva Juan Ramón Jimenez,

Unidad de Salud Mental, Huelva, Spain

Corresponding author.

Introduction

Dual diagnosis is a growing problem in Western

society, despite which there are no large studies examining this

issue, nor specific protocols to address them.

Objectives

To raise awareness of the importance of dual diagno-

sis both its prevalence and special features that presents need a

different performance plan from them separately.

Methods

Comprehensive literature review of all published in the

last 2 years, as well as the specific features.

Conclusion

Dual diagnosis has very specific characteristics that

we must know in order to develop therapeutic strategies adapted

to the present conditions.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1379

EV395

Health-related quality of life in

patients with moderate-severe

psoriasis: Preliminary results on the

role of psychopathology and coping

strategies in a cohort of patients

M. Fabrazzo

1 ,

, V. De Santis

1

, R.V. Puca

2

, F. Romano

2

,

M. Arrigo

1

, V. Cioffi

1

, F. Catapano

1

, A. Lo Schiavo

2

1

University of Naples SUN, department of psychiatry, Naples, Italy

2

University of Naples SUN, department of dermatology, Naples, Italy

Corresponding author.

Psoriasis is a multisystem inflammatory disease associated to

several comorbidities with a significant impact on interper-

sonal and social life. Depression, anxiety symptoms and suicidal

ideation–due to psychological distress–are frequently reported.

The aim of the study was to assess whether psychological

factors–psychopathology, perceived health status and coping

strategies–together with clinical and sociodemographic factors,

were independent predictors of Quality of Life (QoL) in adult psori-

atic patients on topical and/or systemic pharmacological therapy. A

cohort of 87 patients (53 Mand 34 F), whosemean agewas 46

±

22

years, was analyzed. Coping responses were assessed by COPE and

general psychopathology by Self-Reported-Symptom Inventory

Revised (SCL-90), while HAM-D and HAM-A evaluated depressive

and anxiety symptoms. In addition, perceived health status and

QoL were analyzed by Short-Form-36 (SF-36) while the disease’s

burden assessed by PSODISK. Univariate analyses were performed

for each variable to explore the relationship with QoL. Preliminary

results indicated that, although not severe, anxiety and depres-

sive symptoms were the most reported among patients along with

somatization and obsessive-compulsivity. Female patients used

more frequently mental disengagement, focus on and venting of

emotions, use of instrumental social support and religious cop-

ing. Physical pain and mental health, instead, greatly affected QoL

of subjects in a negative manner. PSODISK data analysis showed

that general health, itching, serenity, shame and degree of exten-

sion of the disease on the skin were the most compromised areas.

Moreover, correlation analysis indicated that a worse perception of

patients’ health status was associated to poor QoL.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1380

EV396

Epilepsy and self-esteem

M. Turki

1 ,

, I. B

ouchhima

1 , N.

Halouani

2 , E. T

urki

1 ,

N. Bouzidi

1 , M.

Dammak

1 , O.

Amami

2 , C. M

hiri

1

1

Habib Bourguiba university hospital, neurology department, Sfax,

Tunisia

2

Hedi Chaker university hospital, psychiatry department, Sfax,

Tunisia

Corresponding author.

Introduction

Epilepsy is a public health problemthat often affects

personal and social patients’ life. Self-esteem, an important factor

contributing to psychosocial well-being, is generally disrupted in

epilepsy.